MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s43856-025-01273-z

Медицинская библиотека · Communications medicine · 2026

Genomic epidemiology of SARS-CoV-2 in Peru from 2020 to 2024.

Sobkowiak Benjamin, Langdon Amy, Romero Pedro E, Carrasco-Escobar Gabriel, Villa Diego, Cava Miller Renato, Cornejo Villanueva Víctor, Dávila-Barclay Alejandra, Cuicapuza Diego, Salvatierra Guillermo, González Luis, Ayzanoa Brenda, Huancachoque Janet, Marcos-Carbajal Pool, Gómez de la Torre Juan Carlos, Barletta Claudia, Chenet Stella M, Tapia-Limonchi Rafael, Ballón Jorge, Fernández Patrick, Valderrama Rosario, Leguía Mariana, Delgado-Ratto Christopher, Gotuzzo Eduardo, Zamudio Carlos, Lescano Willy, Cárcamo César, Hurtado Verónica, Lope-Pari Priscila, Padilla-Rojas Carlos, Jiménez-Vásquez Víctor, Escalante-Maldonado Oscar, Araujo-Castillo Roger V, Cabezas César, Colijn Caroline, Tsukayama Pablo

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Peru recorded one of the world's highest COVID-19 mortality rates, with nearly 4.5 million reported cases and 220,000 deaths by March 2024. Understanding the emergence and spread of SARS-CoV-2 variants in this context is key to informing effective public health responses. This study describes the genomic diversity, transmission dynamics, and geographic spread of SARS-CoV-2 in Peru from 2020 to 2024.

METHODS

We analyzed nearly 50,000 high-quality public SARS-CoV-2 genome sequences collected nationwide between March 2020 and March 2024. Phylogeographic and mutational analyses were performed to identify variant lineages, trace their origins, and map viral movements within and beyond Peru.

RESULTS

We show that Peru's epidemic waves were shaped by the emergence of locally evolved variants, including Lambda (C.37), Gamma (P.1.12), and Omicron (XBB.2.6 and DJ.1) sub-lineages. The city of Lima acted as the primary hub for inter-regional spread, accounting for 47.3% of inferred viral movements to other departments, notably Ancash, Cusco, and Piura. Peru was the source of various lineages that spread internationally, primarily to Chile, the USA, and Europe. Mutational analysis highlighted critical mutations in the spike protein, including L452Q and F490S in Lambda, associated with immune evasion and increased transmissibility.

CONCLUSIONS

This work demonstrates the capacity of genomic surveillance in Peru to detect and track emerging SARS-CoV-2 variants, providing insights into regional and global transmission dynamics in a high-transmission, middle-income country setting. Sustained, cost-effective genomic monitoring, combined with strengthened bioinformatics and laboratory capacity, is essential for pandemic preparedness in resource-limited settings.

Для цитирования: Sobkowiak Benjamin, Langdon Amy, Romero Pedro E, Carrasco-Escobar Gabriel, Villa Diego, Cava Miller Renato, Cornejo Villanueva Víctor, Dávila-Barclay Alejandra, Cuicapuza Diego, Salvatierra Guillermo, González Luis, Ayzanoa Brenda, Huancachoque Janet, Marcos-Carbajal Pool, Gómez de la Torre Juan Carlos, Barletta Claudia, Chenet Stella M, Tapia-Limonchi Rafael, Ballón Jorge, Fernández Patrick, Valderrama Rosario, Leguía Mariana, Delgado-Ratto Christopher, Gotuzzo Eduardo, Zamudio Carlos, Lescano Willy, Cárcamo César, Hurtado Verónica, Lope-Pari Priscila, Padilla-Rojas Carlos, Jiménez-Vásquez Víctor, Escalante-Maldonado Oscar, Araujo-Castillo Roger V, Cabezas César, Colijn Caroline, Tsukayama Pablo. Genomic epidemiology of SARS-CoV-2 in Peru from 2020 to 2024.. Communications medicine. 2026. DOI: 10.1038/s43856-025-01273-z.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.